The Column for Bioassay Validation

Analysis of key terms in bioassay*

Expand
  • NMPA Key Lab for Guality Research and Evaluation of Chemical Drug, National Institutes for Food and Drug Control, Beijing 102629, China

Received date: 2022-03-18

  Online published: 2024-06-24

Abstract

The whole life cycle study of bioassay is an important content of pharmacology. It is widely used in the fields of drug activity determination, new drug research and physiological activity determination of hormones and neurotransmitters. It still plays an irreplaceable role in the determination of some drugs, especially biochemical drugs. Bioassay is different from other physical and chemical determination methods because of its own characteristics and complicated analysis of statistics. Therefore, this kind of method involves more professional terms, which is prone to be confused in understanding and use. The correct understanding of terms is the fundamental basis for the research work related to bioassay. Therefore, this paper makes a preliminary summary and analysis of some key terms in bioassay (eg. method suitability, replicate, parallelism), in order to be helpful for relevant analysts to carry out bioassay.

Cite this article

ZHANG Yuan, GUO Long-jing, TAN De-jiang . Analysis of key terms in bioassay*[J]. Chinese Journal of Pharmaceutical Analysis, 2022 , 42(6) : 937 -941 . DOI: 10.16155/j.0254-1793.2022.06.03

References

[1] 张媛,谭德讲. 中国药典生物检定统计实例不同计算方式结果比较和几点修改建议[J].药物分析杂志,2013,33(11):1858
ZHANG Y, TAN DJ. Comparison of results of bioassay examples in Chinese Pharmacopeia with different calculation methods and some revising suggestions[J].Chin J Pharm Anal, 2013, 33(11): 1858
[2] 卢志兵. 对《中国药典》(2015版)中1431生物检定法的六点探讨[J].中国药品标准, 2021,22(2):110
LU ZB. Discussion on general chapters 1431 in the Chinese Pharmacopoeia 2015[J].Drug Stand China, 2021, 22(2): 110
[3] 中华人民共和国药典2020年版. 四部 [S].2020:206,530
ChP 2020. Vol Ⅳ [S].2020: 206, 530
[4] USP 42-NF 37[S].2019:6468, 7185, 7205, 7222, 7236
[5] 汤思敏. 关于中医术语翻译原则的探讨[J].中医学报,2010,25(3):555
TANG SM. On the principles of translation of TCM terms[J].China J Chin Med, 2010, 25(3): 555
[6] 李娜,杜颖,刘翠,等. 生物活性检测方法的定义及分类辨析[J].药物分析杂志,2022,42(6):931
LI N, DU Y, LIU C, et al. Definition and taxonomy of bioassay[J].Chin J Pharm Anal, 2022, 42(6):931
[7] 徐勇勇, 韦丽琴, 刘丹红. 医学统计教材内容的标准化问题[J].中国卫生统计,2004, 21(6): 341
XU YY, WEI LQ, LIU DH. Standard issues in medical statistical textbooks[J].Chin J Health Stat, 2004, 21(6): 341
[8] 项荣武,梁露华,党丹,等. 中、美、欧药典关于生物检定统计法的比较[J].沈阳药科大学学报,2014,31(10):819
XIANG RW, LIANG LH, DANG D, et al. A comparison of the bioassay statistical method in ChP with those in USP and EP[J].J Shenyang Pharm Univ, 2014, 31(10): 819
[9] 周海均. 药品生物检定[M].北京:人民卫生出版社,2005:135,160
ZHOU HJ. Drug Bioassay[M].Beijing: People’s Medical Publishing House, 2005:135,160
Outlines

/